Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs' innovative biologic.
India's strategy against Covid was more effective than any other countries in the world
The session took place in the presence of Union Ministers Hardeep Singh Puri and Gen V K Singh along with Anil Agarwal, Rajya Sabha Member of Parliament
To enable company to be future-ready by tapping potential in CDMO space
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.
Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand
Extends patent protection for Microbion's proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039
Subscribe To Our Newsletter & Stay Updated